Literature DB >> 26282641

Combined-Modality Therapy for Early-Stage Diffuse Large B-Cell Lymphoma: Knowing When to Quit.

Dan L Longo1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26282641     DOI： 10.1200/JCO.2015.63.0285

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  [Is consolidative radiotherapy needed after chemotherapy in early stage diffuse large B‑cell lymphoma?].

Authors:  Carsten Nieder
Journal:  Strahlenther Onkol       Date:  2016-05       Impact factor: 3.621

2.  Patient Survival With and Without Radiation Therapy for Early-Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab.

Authors:  Christopher McLaughlin; Anthony Ricco; Raj Singh; Nitai Mukhopadhyay; Nevena Skoro; Selamawit Girma; Xiaoyan Deng; Shiyu Song
Journal:  Adv Radiat Oncol       Date:  2022-02-28

3.  R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.

Authors:  Thierry Lamy; Gandhi Damaj; Pierre Soubeyran; Emmanuel Gyan; Guillaume Cartron; Krimo Bouabdallah; Rémy Gressin; Jérôme Cornillon; Anne Banos; Katell Le Du; Mohamed Benchalal; Marie-Pierre Moles; Steven Le Gouill; Joel Fleury; Pascal Godmer; Hervé Maisonneuve; Eric Deconinck; Roch Houot; Kamel Laribi; Jean Pierre Marolleau; Olivier Tournilhac; Bernard Branger; Anne Devillers; Jean Philippe Vuillez; Thierry Fest; Philippe Colombat; Valérie Costes; Vanessa Szablewski; Marie C Béné; Vincent Delwail
Journal:  Blood       Date:  2017-10-23       Impact factor: 25.476
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.